DCF — ADVENTIST HEALTH GLENDALE
Enterprise Value: $-1.1B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.1B
Enterprise Value
$-333.1M
PV of Cash Flows
$-738.7M
PV of Terminal Value
$-1.2B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $492.8M | $-70.0M | -14.0% | $-90.9M | $-82.6M |
| Year 2 | $507.6M | $-67.1M | -13.0% | $-88.6M | $-73.2M |
| Year 3 | $522.8M | $-63.8M | -12.0% | $-86.0M | $-64.6M |
| Year 4 | $538.5M | $-63.1M | -12.0% | $-85.9M | $-58.6M |
| Year 5 | $554.7M | $-63.6M | -11.0% | $-87.1M | $-54.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.1B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$478.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.14712235623043546
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5